Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04323839 · ClinicalTrials.gov registry record
COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY)
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 1,333
- Enrollment target
NCT04323839: Completed study, sponsored by University of California, San Francisco.
NCT04323839 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 1,333 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04323839 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 1,333 participants
- Enrollment target
Study Summary
PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) is a prospective cohort study of pregnant and recently pregnant women who are: either patients under investigation for COVID-19 or a confirmed case of COVID-19. Data from PRIORITY will be used to evaluate the impact of COVID-19 on the clinical course and pregnancy outcomes of pregnant women and women within 6 weeks of pregnancy.
Primary Outcome
presenting symptoms and testing
Interventions
- OTHER Pregnant women under investigation for Coronavirus or diagnosed with COVID-19
- OTHER Postpartum women under investigation for Coronavirus or diagnosed with COVID-19
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,333 participants |
| Start Date | 2020-03-20 |
| Est. Completion | 2022-04-26 |
What the finished NCT04323839 record still lists
NCT04323839 is an observational study that tracks outcomes without assigning an intervention. Its 1,333 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Pregnant women under investigation for Coronavirus or diagnosed with COVID-19 is the first listed.
NCT04323839 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04323839 about?
NCT04323839 is a clinical study titled "COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY)". PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) is a prospective cohort study of pregnant and recently pregnant women who are: either patients under investigation for COVID-19 or a confirmed case of COVID-19. Data from PRIORITY will be used to evaluate the impact of COVID-19 on the clinical cours...
What is the current status of trial NCT04323839?
This trial is currently completed. The enrollment target is 1,333 participants. The study started on 2020-03-20. Estimated completion is 2022-04-26.
What interventions are being tested in trial NCT04323839?
The interventions under investigation include: Pregnant women under investigation for Coronavirus or diagnosed with COVID-19 (OTHER), Postpartum women under investigation for Coronavirus or diagnosed with COVID-19 (OTHER).
Who is sponsoring clinical trial NCT04323839?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05415761 · 1,332 participants · NA
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care
- NCT05511298 · 1,332 participants
Empowering Students Project
- NCT06934876 · 1,332 participants
Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults
- NCT06972056 · 1,335 participants · Phase 4
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI